参考文献/References:
［1］ DILMAN V M.Age-associated elevation of hypothalamic，threshold to feedback control，and its role in development，ageine，and disease［J］.Lancet，1971，297(7711)：1211-1219.
［2］ EVANS J M，DONNELLY L A，EMSLIE-SMITH A M，et al.Metformin and reduced risk of cancer in diabetic patients［J］.BMJ，2005，330(7503)：1304-1305.
［3］ BOWKER S L，MAJUMDAR S R，VEUGELERS P，et al.Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin［J］.Diabetes Care，2006，29(2)：254-258.
［4］ LIBBY G，DONNELLY L A，DONNAN P T，et al.New users of metformin are at low risk of incident cancer：a cohort study among people with type 2 diabetes［J］.Diabetes Care，2009，32(9)：1620-1625.
［5］ DECENSI A，PUNTONI M，GOODWIN P，et al.Metformin and cancer risk in diabetic patients：a systematic review and meta-analysis［J］.Cancer Prev Res，2010，3(11)：1451-1461.
［6］ CURRIE C J，POOLE C D，GALE E A.The influence of glucose-lowering therapies on cancer risk in type 2 diabetes［J］.Diabetologia，2009，52(9)：1766-1777.
［7］ LEE J H，KIM T I，JEON S M，et al.The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus［J］.Int J Cancer，2012，131(3)：752-759.
［8］ PISANI P.Hyper-insulinaemia and cancer，meta-analyses of epidemiological studies［J］.Arch Physiol Biochem，2008，114(1)：63-70.
［9］ NING J，CLEMMONS D R.AMP-activated protein kinase inhibits IGF-I signaling and protein synthesis in vascular smooth muscle cells via stimulation of insulin receptor substrate 1 S794 and tuberous sclerosis 2 S1345 phosphorylation［J］.Mol Endocrinol，2010，24(6)：1218-1229.
［10］ ROZENGURT E，SINNETT-SMITH J，KISFALVI K.Crosstalk between insulin/insulin-like growth factor-1 receptors and G protein-coupled receptor signaling systems：a novel target for the antidiabetic drug metformin in pancreatic cancer［J］.Clin Cancer Res，2010，16(9)：2505-2511.
［11］ ZAKIKHANI M，BLOUIN M J，PIURA E，et al.Metformin and rapamycin have distinct effects on the AKT pathway and proliferation in breast cancer cells［J］.Breast Cancer Res Treat，2010，123(1)：271-279.
［12］ OUYANG J，PARAKHIA R A，OCHS R S.Metformin activates AMP kinase through inhibition of AMP deaminase［J］.J Bioll Chem，2011，286(1)：1-11.
［13］ RATTAN R，GRAHAM R P，MAGUIRE J L，et al.Metformin suppresses ovarian cancer growth and metastasis with enhancement of cisplatin cytotoxicity in vivo［J］.Neoplasia，2011，13(5)：483-491.
［14］ LIAO H，ZHOU Q，GU Y，et al.Luteinizing hormone facilitates angiogenesis in ovarian epithelial tumor cells and metformin inhibits the effect through the mTOR signaling pathway［J］.Oncol Rep，2012，27(6)：1873-1888.
［15］ BEN SAHRA I，LAURENT K，LOUBAT A，et al.The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level［J］.Oncogene，2008，27(25)：3576-3586.
［16］ ZHUANG Y，MISKIMINS W K.Cell cycle arrest in Metformin treated breast cancer cells involves activation of AMPK，downregulation of cyclin D1，and requires p27Kip1 or p21Cip1［J］.J Mol Signal，2008，3：18.
［17］ RATTAN R，GIRI S，HARTMANN L C，et al.Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner［J］.J Cell Mol Med，2011，15(1)：166-178.
［18］ YASMEEN A，BEAUCHAMP M C，PIURA E，et al.Induction of apoptosis by metformin in epithelial ovarian cancer：involvement of the Bcl-2 family proteins［J］.Gynecol Oncol，2011，121(3)：492-498.
［19］ HIRSCH H A，ILIOPOULOS D，TSICHLIS P N，et al.Metformin selectively targets cancer stem cells，and acts together with chemotherapy to block tumor growth and prolong remission［J］.Cancer Res，2009，69(19)：7507-7511.
［20］ SHANK J J，YANG K，GHANNAM J，et al.Metformin targets ovarian cancer stem cells in vitro and in vivo［J］.Gynecol Oncol，2012，127(2)：390-397.
［21］ TSILCHOROZIDOU T，MOHAMED-ALI V，CONWAY G S.Determinants of interleukin-6 and C-reactive protein vary in polycystic ovary syndrome，as do effects of short- and long-term metformin therapy［J］.Horm Res，2009，71(3)：148-154.
相似文献/References:
[1]陈建丽,胡新荣.p16在肿瘤中的表达与人乳头瘤病毒感染的关系[J].新乡医学院学报,,():000.
[2]张明彩 贾红霞 赵卫星 秦志强 付佶.乳腺浸润性导管癌冰冻与石蜡切片细胞核的形态计量对比研究[J].新乡医学院学报,1999,16(02):110.
[3]周文科 综述 张新中 审校.岩斜区侧方手术入路的研究进展[J].新乡医学院学报,2000,17(06):470.
[4]于维霞,王玉红 郭悦鹏,杜荣,等.T细胞亚群测定鉴别结核性与癌性胸腔积液[J].新乡医学院学报,2000,17(01):032.
[5]刘 薇.妇科肿瘤25例动脉插管化疗的观察与护理[J].新乡医学院学报,2003,20(03):003.
[6]刘薇.妇科肿瘤25例动脉插管化疗的观察与护理[J].新乡医学院学报,2003,20(03):001.
[7]王磊,乔庆东,王光军,等.微创腔镜技术治疗输尿管梗阻72 例[J].新乡医学院学报,2010,27(06):610.
[8]郭康,李文才.运动相关蛋白1/CD9在肿瘤中的表达研究进展[J].新乡医学院学报,2010,27(04):419.
[9]张莉莉,黄青松.肿瘤干细胞的起源、分离及鉴定研究进展[J].新乡医学院学报,2012,29(01):000.
[10]职晓松,黄筱奕,訾晓渊,等.长链非编码RNA PVT1在肿瘤中的作用研究进展[J].新乡医学院学报,2016,33(3):243.[doi:10.7683/xxyxyxb.2016.03.022]
ZHI Xiaosong,HUANG Xiaoyi,ZI Xiaoyuan,et al.Research progress on the role of long-chain noncoding RNAPVT1 in tumors[J].Journal of Xinxiang Medical University,2016,33(2):243.[doi:10.7683/xxyxyxb.2016.03.022]